Schering Sales Force Recruitment Is 80% Complete; Morale Remains High
Executive Summary
Recruitment for Schering-Plough's sales force expansion is 80% complete, Global Pharmaceutical President Carrie Cox told investors during a year-end conference call Jan. 26
You may also be interested in...
Schering Acquires Levitra Rights From Bayer; Vytorin Launch Is Still Priority
Schering-Plough's acquisition of Bayer's primary care products in the U.S. will not distract the company from the launch of Vytorin, Schering CEO Fred Hassan told investors Sept. 13 at a Bear Stearns conference in New York
Schering Acquires Levitra Rights From Bayer; Vytorin Launch Is Still Priority
Schering-Plough's acquisition of Bayer's primary care products in the U.S. will not distract the company from the launch of Vytorin, Schering CEO Fred Hassan told investors Sept. 13 at a Bear Stearns conference in New York
Roche, Schering Look To Grow Hepatitis Market; Pegasys Share Surges
Roche and Schering-Plough are attempting to drive sales of their hepatitis products by growing the market while increasing share